Answer #1: The present DCVAX-Direct platform was not used in the Triozzi study from early 2002. It was not in existence yet. The present DCVAX-Direct platform is the more potent, perfectly staged dendritic technology born out of the Maurine studies and one small human study.
Answer #2: I believe the present DCVAX-Direct is the culmination of many years work to study and enhance the dendritic technology used in the original Triozzi vaccine. NWBO took up Triozzi's challenge, and here is the end product.